Vyrologix
-
Business/News
CytoDyn Inc., Biotechnology Company developing CCR5
CytoDyn Inc., a late-stage biotechnology company developing CCR5 inhibiting drug leronlimab- Vyrologix, showed impressive results in improving the immune function of critically ill COVID-19 patients…
Read More »